Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Temporal proteomics reveal specific cell cycle oncoprotein downregulation by p97/VCP inhibition. | Cell Chem Biol | 2022 | 34847375 | PubTator, text mining | PubMed |
| The extracellular matrix of hematopoietic stem cell niches. | Adv Drug Deliv Rev | 2022 | 34838648 | PubTator, text mining | PubMed |
| Strategies for developing complex multi-component in vitro tumor models: Highlights in glioblastoma. | Adv Drug Deliv Rev | 2022 | 34822927 | PubTator, text mining | PubMed |
| Hypoxia modulates human mast cell adhesion to hyaluronic acid. | Immunol Res | 2022 | 34791576 | PubTator, text mining | PubMed |
| In vivo multimodal imaging of hyaluronan-mediated inflammatory response in articular cartilage. | Osteoarthritis Cartilage | 2022 | 34774790 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts-derived HAPLN1 promotes tumour invasion through extracellular matrix remodeling in gastric cancer. | Gastric Cancer | 2022 | 34724589 | PubTator, text mining | PubMed |
| Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis. | Pancreatology | 2022 | 34657790 | PubTator, text mining | PubMed |
| Modulation of hyaluronan signaling as a therapeutic target in human disease. | Pharmacol Ther | 2022 | 34587477 | PubTator, text mining | PubMed |
| Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: From intrinsic physicochemical properties to external modification. | Bioact Mater | 2022 | 34541398 | PubTator, text mining | PubMed |
| Coronary Microvascular Dysfunction and Heart Failure with Preserved Ejection Fraction - implications for Chronic Inflammatory Mechanisms. | Curr Cardiol Rev | 2022 | 34488616 | PubTator, text mining | PubMed |
| Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2022 | 34405552 | PubTator, text mining | PubMed |
| The critical role of B4GALT4 in promoting microtubule spindle assembly in HCC through the regulation of PLK1 and RHAMM expression. | J Cell Physiol | 2022 | 34270095 | PubTator, text mining | PubMed |
| Hyaluronan, a double-edged sword in kidney diseases. | Pediatr Nephrol | 2022 | 34009465 | PubTator, text mining | PubMed |
| Overexpression of CD168 is related to poor prognosis in oral squamous cell carcinoma. | Oral Dis | 2022 | 33386685 | PubTator, text mining | PubMed |
| A COMPOSITIONAL MODEL TO ASSESS EXPRESSION CHANGES FROM SINGLE-CELL RNA-SEQ DATA. | Ann Appl Stat | 2021 | 37332668 | PubTator, text mining | PubMed |
| Nanocarrier drug resistant tumor interactions: novel approaches to fight drug resistance in cancer. | Cancer Drug Resist | 2021 | 35582024 | PubTator, text mining | PubMed |
| Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2021 | 35232899 | PubTator, text mining | PubMed |
| The Role of the Extracellular Matrix in Neural Progenitor Cell Proliferation and Cortical Folding During Human Neocortex Development. | Front Cell Neurosci | 2021 | 35140590 | PubTator, text mining | PubMed |
| The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma. | Front Oncol | 2021 | 35127523 | PubTator, text mining | PubMed |
| Identification of hub genes in key hallmarks of ovarian cancer via bioinformatics analysis. | Transl Cancer Res | 2021 | 35116413 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=32